Citation:
Du R, Yang H, Zhou H, Ma L, Getu MA, Chen C, Wang T. Home-based multidisciplinary interventions on skin adverse reactions in EGFR-The Kids-treated patients with lung cancer: a protocol for a randomised controlled trial. BMJ Open. 2022;12(11):e063921.
Keywords:
Clinical pharmacology; complementary medicine; dermatology; oncology;
EGFR protein; epidermal growth factor receptor; protein kinase; inhibitor; adverse drug reaction; lung tumor; non small cell lung cancer; quality of life; randomized controlled trial
Abstract:
Here, we provide a feasible, well-designed protocol of a randomised controlled trial for the assessment of the effects of a home-based multidisciplinary intervention on the severity of skin adverse drug reactions and health-related indicators in patients with non-small cell lung cancer (NSCLC) under epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-The Kids) therapy.